FMO5 and Insulin resistance: Elevated levels of angiotensin II (Ang II) (a pro-inflammatory adipokine) lead to the upregulation of NAD(P)H oxidase through the Ang II type 1 receptor, increase the production of ROS, and are involved, together with endothelial dysfunction, in the pathogenesis of insulin resistance [31,32].